Thank you, Seth and good afternoon everyone. Q4 and fiscal year 2021 results, revenue for the fourth quarter was $99.3 million and full your revenue was $374.4 million, a year-over-year increase of 13% and 14.6%, respectively. Annualized recurring revenue was $393 million, a year over year increase of 12.6%. Revenue retention rate for service subscriptions, which makes up 98.7% of our revenue was 92%, with more than 80% of subscription revenue, non cancelable for at least 12 months on a rolling basis. For the fourth quarter and full year, clients within the United States represented 53% of total revenue, while international clients contributed 47%. Aggregate year-over-year revenue growth in the United States was 7.7% for the fourth quarter, and 4.4% for the full year, while growth for international clients was 19.6% for the fourth quarter and 29% for the full year. On a cash flow basis, for full year 2021, we generated $67 million of operating cash flow, up 59% from the prior year. The increase was driven by strong renewals, and by robust multi-year client prepayments. We are quite pleased with our cash flow yield of 17.9% for the year as our focus on maintaining significant operating cash flow generation, combined with our drastically reduced cost of capital provides us with the ability to take advantage of key strategic opportunities that were not previously feasible. Billings for the fourth quarter were $155.9 million compared to $140.5 million for the prior year, an increase of 11% and full year billings were $417.8 million compared to $348.2 million, an increase of 20%. Multi-year prepayments for both renewals and for new client invoicing were strong throughout the year. Gross margin was 65.1% for the fourth quarter and 63.6% for the full year 2021, which is well above our initial and upwardly revised guidance range of 61.5% to 62.5% compared to 61.8% for the prior year fourth quarter and 61.4% for full year 2020. We are pleased with our service delivery throughout 2021 and continue to methodically expand efficiencies, and leverage through technology and process control. We expect to continue investing in the global service delivery capability and capacity for our new products, services and solutions to ensure we can deliver our best-in-class offerings with unparalleled client satisfaction. Therefore, for full year 2022, we are guiding gross margin to be in the range of 62.5% to 63.5% on a GAAP basis, and 63$ to 64% on a non-GAAP basis. Operating expenses, like other companies globally, we are experiencing some cost pressures due to increased labor costs and inflation. However, we are successfully mitigating this challenge in part by broadening our hiring practices with an emphasis to recruit more positions in lower cost geographies and in part by using innovative technology, such as our recently issued US patent to gain more operating leverage. We plan to continue exploring all options available to ensure we are able to acquire the right talent at the right cost to meet our profitability and growth targets. Sales and marketing expenses as a percentage of revenue was 32.7% for the fourth quarter and 34.3% for full year 2021, below our guidance range compared to 34.5% for the prior year, fourth quarter, and 35.1% for full year 2020. We remain focused on making the appropriate investments needed to support our growth initiatives whereby we expect full year 2022 sales or marketing expenses to be in the range of 34.5% to 35.5% on a GAAP basis, and 34% to 35% on a non GAAP standpoint, General and administrative expenses as a percentage of revenue, excluding outside litigation costs was 15.6% for the fourth quarter and 17.1% for full year 2021 at the top end of our upwardly revised guidance compared to 16% for both the prior year fourth quarter and full year 2020. These one-time items occurred in the first half of the year and as such, we do note that our, G&A expenses did decline nearly 10% in the second half of the year, versus the first half. Current and expected 2022 spend includes the investment in information systems, along with costs for additional personnel to support growth and cost as a public company and to support our continuing global compliance monitoring of our service delivery process, and incremental professional, legal, audit and insurance costs. As a result, we expect G&A expenses as a percentage of revenue to be within the range of 16% to 17% for the full year 2022 and 14.5% to 15.5% on a non-GAAP basis. Net outside litigation expense was $2.7 million for the fourth quarter and $16.9 million for full year 2021, at the high-end of our guidance range, compared to $4.2 million for the prior year fourth quarter and $14.6 million for full year 2021. During the fourth quarter, we received an insurance recovery of $7.1 million for attorney costs related to Oracle litigation. In addition, we paid 630,000 to Oracle for court ordered sanctions, and we accrued $6.9 million as an estimate for court ordered reimbursement or go for reasonable legal fees. However, as Seth noted, we are appealing the district court's ruling. And we do not expect the resolution of our forthcoming appeal. Possible reimbursement of some or all of the 630,000 in sanctions paid for the amount of Oracle legal fees that may or may not be payable, if any at all, for likely at least a year or more. Outside litigation spend is not linear and can fluctuate each quarter, based on timing and the nature of litigation activities. We expect a likely moderate increase in litigation spend in 2022, compared to 2021, due to the noted appeal in preparation for the Rimini II Trial, which we expect more than likely occur in 2023. Accordingly, we expect outside litigation expense to be in the range of 15 million to 20 million for the full year 2022, compared to $16.9 million for full year 2021. For the fourth quarter, net income was $70.1 million or $0.77 per common share and $75.2 million for full year 2021 or $0.51 per common share. This compares to the prior year fourth quarter loss of $4.2 million or negative $0.6 per common share, and for prior full year 2020, a loss of $15.2 million or negative $0.21 per common share. Given the cumulative profitability of a recent years and our outlook for continued profitability, we should benefit from our deferred tax assets and therefore recorded deferred income tax gain during the fourth quarter. This gain of $62.3 million, which was offset by current income tax expense, led to a net income tax benefit in the fourth quarter of $60 and $55.8 million for the full year. Moreover, our EPS was also positively impacted by the redemption in full of the Series A, preferred in the third quarter, as a result of which there are no longer any costs associated with this instrument negatively impacting earnings per share. Adjusted EBITDA was $19.3 million or 19.4% of revenue for the fourth quarter and $55.8 million or 14.9% of revenue for full year 2021. Also, I would like to highlight our non-GAAP operating margin, which excludes outside litigation spend, and stock-based compensation of 19.5% for the fourth quarter and 14.7% for full year 2021. That underscores the significant profitability potential and substantial leverage to our operating model such that we remain confident in our ability to achieve our long-term target of operating margins in excess of 20%. Warrant treatment, we realized a non-cash loss of $1.2 million during the fourth quarter and $4.2 million for full year 2021 relating to the $6.1 million private sponsor warrants with an exercise price of $11.50 that expire October 10, 2022. The condition that required liability accounting treatment is no longer in effect, and the settlement of this non-cash charge was applied to additional paid in capital. Therefore, going forward, there is no longer a requirement of mark-to-market for any class of warrants such that we do not anticipate any further income statement impact associated with regard to the public or private value of any outstanding warrants. Balance sheet. We ended the fourth quarter with a record cash balance of $119.6 million, compared to $87.6 million for the prior year fourth quarter, up 36% year-over-year. This represents a positive swing in net liquidity of more than $100 million as we ended 2021 with a net cash position of $36.3 million versus a $67.3 million net debt position at the end of 2020. Deferred revenue as of December 31, 2021, was approximately $300 million, up 17% from $257 million for the prior year fourth quarter. Backlog, which includes the sum of build deferred revenue and non-cancelable future revenue was approximately $593 million as of December 31, 2021, up 7% from $556 million for the prior year fourth quarter. Capital market transactions. As Seth noted, today, we announced that our Board of Directors has authorized the repurchase of up to $15 million of common stock over the next two years. The common stock repurchases may be effected through open market purchases, including through the use of Rule 10b5-1 trading plans or privately negotiated transactions. The timing and amount of common stock repurchases made pursuant to the repurchase program are subject to various factors, including but not limited to the company's common stock trading price, regulatory requirements, credit agreement covenants, general market conditions and alternate uses of capital. The company is not, however, required to acquire any particular amount of common stock at a specific time or price, and repurchases can be discontinued at any time without notice. With a strong cash position and consistent operating cash flow generation model, we believe the company is able to both continue funding growth, while implementing this capital return plan for our shareholders. We plan to continue our methodical focus on improving execution to drive increasing free cash flow generation and improved profitability. Business Outlook, we’re currently providing first quarter 2022 revenue guidance to be in the range of $95 million to $96 million and full year 2022 revenue guidance to be in the range of $400 million to $410 million. This concludes our prepared remarks. Operator, we’ll now take questions.